Wales follows Scotland and Northern Ireland in implementing low risk diabetic eye screening pathway
Wales has followed Scotland and Northern Ireland in implementing the UK NSC's recommendation for a low risk diabetic eye screening pathway.
Mike Harris
Mike is the head of UK NSC transparency and public understanding. A former journalist, he has worked in screening since 2010.
Progress on practical projects to support the UK NSC in making newborn blood spot screening recommendations
A summary note has been published of the latest meeting of the UK National Screening Committee's Blood Spot Task Group when members were updated on progress on 4 of its 5 core projects.
Exciting opportunities to join one of the UK NSC’s expert groups
Apply for one of 12 exciting vacancies in the expert reference groups that support the UK National Screening Committee.
Simple screening comparisons between countries mask complex differences
Variation in how health services are delivered and funded, how screening is described and how screening policy is made help explain differences between countries and regions in what conditions they screen for.
UK NSC recommends introduction of screening for tyrosinaemia in newborns
The UK National Screening Committee is recommending the introduction of screening for tyrosinaemia as part of the newborn blood spot screening programme.
UK NSC receives record number of annual call screening proposals
The UK National Screening Committee (UK NSC) received a record number of 29 proposals during its 2022 annual call for topics. This is by far the most submissions it has received in a single year since the annual call process started in 2016.
UK NSC public engagement on genome sequencing wins prestigious award
A public dialogue on the implications of whole genome sequencing (WGS) for newborn screening, commissioned by the UK NSC, has won the 2022 Market Research Society (MRS) award for public policy/social research.
Work starts on reviewing the case for screening for SMA
Researchers start work on new project to review evidence for newborn screening for spinal muscular atrophy.
The role of patient and public voice members on the UK NSC
Find out more about the role of the UK NSC's patient and public voice members (PPVs) and the essential contribution they make to the work of the committee.
Why evidence maps are the UK NSC’s first step in reviewing screening evidence
Using evidence maps as the first stage in its evidence review process helps the UK NSC focus its more detailed work on topics where there is the most significant new evidence.